Ornithobacterium rhinotracheale (ORT): A Comprehensive Guide to Respiratory Disease in Poultry
Introduction
Ornithobacterium rhinotracheale (ORT) is a Gram-negative, rod-shaped, non-spore-forming bacterium that causes ornithobacteriosis, an emerging respiratory disease in commercial poultry worldwide. The pathogen primarily affects turkeys and chickens but has been isolated from a wide range of avian species including pigeons, ducks, geese, pheasants, and wild birds [45, 63, 68, 84]. ORT infection contributes to substantial economic losses through increased mortality, reduced weight gain, slaughterhouse condemnations due to airsacculitis, and costs associated with treatment and control measures [1, 2, 94].
This article provides a comprehensive review of ORT, focusing on its etiological characteristics, pathogenesis, clinical manifestations, diagnostic approaches, antimicrobial resistance patterns, treatment options, control strategies, and economic impact.
Etiology and Taxonomy
ORT belongs to the family Weeksellaceae within the phylum Bacteroidetes. The bacterium is pleomorphic, appearing as rod-shaped or filamentous cells, and is 0.2–0.7 μm wide by 1–3 μm long. It is non-motile, catalase-negative, oxidase-positive, and requires a microaerophilic to capnophilic atmosphere for optimal growth. ORT colonies on blood agar are small (0.5–1 mm), convex, grayish, and may produce a characteristic sweetish odor. The organism does not grow on MacConkey agar.
The genome of ORT is approximately 2.3–2.6 Mb in size with a G+C content of 35–37% [3, 4, 59]. Whole-genome sequencing and comparative genomics have revealed significant genetic diversity among ORT isolates, driven by recombination and horizontal gene transfer [3, 5, 6]. Multilocus sequence typing (MLST) and 16S rRNA gene analysis have been used to classify ORT into distinct phylogenetic clusters [68, 74, 86, 92].
Serotyping
ORT isolates are classified into at least 18 serotypes (A through R) based on differences in outer membrane proteins and lipopolysaccharide composition. Serotypes A, B, C, D, E, and F are most commonly reported in poultry, with serotype A predominant in chickens and serotype C in turkeys, although geographic variation exists [7, 51, 55, 81, 87]. In a study on ORT isolates from turkeys in Poland, serotypes A and C were dominant [7]. Serotype distribution may influence vaccine efficacy and diagnostic test performance.
Pathogenesis
The primary route of ORT infection is inhalation of contaminated aerosols or dust particles. The bacterium adheres to the respiratory epithelium via fimbriae and other adhesins, followed by colonization of the trachea, air sacs, and lungs [80, 96]. ORT produces several virulence factors, including:
- Biofilm formation: Enhances persistence in the respiratory tract and resistance to antimicrobial agents [96].
- Hemagglutinins: Facilitate attachment to host cells.
- Neuraminidase: May degrade mucus and promote tissue invasion.
- Sulfonolipids (e.g., capnine): Involved in gliding motility and membrane integrity, though their exact role in ORT pathogenesis remains under investigation [43].
The host inflammatory response contributes to tissue damage. Infiltration of heterophils and macrophages leads to exudative inflammation, fibrin deposition, and the formation of caseous plugs in airways. Severe cases progress to airsacculitis, pneumonia, and pericarditis [90]. Coinfection with other respiratory pathogens, such as avian metapneumovirus (aMPV), infectious bronchitis virus, avian influenza virus, Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium paragallinarum, Pasteurella multocida, and Escherichia coli, substantially exacerbates disease severity [8, 9, 10, 38, 72, 73, 79, 91, 97, 99].
Clinical Signs and Pathology
The incubation period is typically 3–7 days. Clinical signs vary with host species, age, immune status, and presence of concurrent infections.
Chickens
In broilers, ORT infection often manifests as a mild to moderate respiratory disease with coughing, sneezing, nasal discharge, conjunctivitis, and swollen head syndrome [48, 65]. Mortality is usually low (1–10%) but can increase in the presence of complicating factors. In layers, a drop in egg production may occur. Chronic infections lead to poor growth and increased feed conversion ratio.
Turkeys
Turkeys are more susceptible to severe ORT disease. Clinical signs include depression, anorexia, tracheal rales, gasping, sinusitis, and severe airsacculitis [11, 94]. Mortality rates can reach 30% in untreated flocks. ORT is a leading cause of airsacculitis leading to high condemnation rates at slaughter [11, 1].
Gross Lesions
- Fibrinous airsacculitis (especially thoracic and abdominal air sacs)
- Fibrinous pneumonia
- Tracheitis with mucus or caseous exudate
- Pericarditis
- Perihepatitis in severe cases
Histopathology
Microscopic examination reveals fibrinonecrotic inflammation with heterophil infiltration, edema, and bacterial colonies adherent to the epithelium. Type II pneumocyte hyperplasia and interstitial pneumonia are seen in chronic cases [90].
Diagnosis
A definitive diagnosis of ORT infection requires laboratory confirmation. A combination of culture, molecular methods, and serology is recommended.
1. Bacterial Culture and Isolation
ORT can be isolated from tracheal swabs, air sac swabs, lung tissue, or sinus exudates. Samples should be collected from acutely ill or freshly dead birds. The organism grows on 5% sheep blood agar or chocolate agar under 5–10% CO2 at 37°C for 24–48 hours. Colonies are small, gray, and non-hemolytic. Identification is based on Gram stain morphology, biochemical tests (oxidase-positive, catalase-negative, urease-negative), and commercial identification strips or MALDI-TOF mass spectrometry [51].
2. Molecular Detection
Conventional PCR and qPCR: Numerous PCR assays targeting the 16S rRNA gene, rpoB gene, or species-specific sequences have been developed [12, 13, 40, 44]. Real-time PCR (TaqMan) offers high sensitivity and specificity and can detect ORT in clinical samples with low bacterial loads [44]. Multiplex PCR assays allow simultaneous detection of ORT with other respiratory pathogens such as infectious laryngotracheitis virus and Avibacterium paragallinarum [13].
Loop-mediated isothermal amplification (LAMP): This technique provides rapid, field-deployable detection, though it has been used more extensively for other avian pathogens [76].
Whole-genome sequencing and metagenomic approaches are increasingly used for outbreak investigations, antimicrobial resistance gene profiling, and phylogenetic studies [3, 5, 14, 59].
3. Serology
Enzyme-linked immunosorbent assay (ELISA) kits are commercially available for detecting anti-ORT antibodies in serum or egg yolk. Serology is useful for flock-level surveillance but has limited utility for individual bird diagnosis due to variability in antibody responses [56, 73, 98]. A latex agglutination test (LAT) has been developed for rapid detection of ORT infection in turkeys [15].
Diagnostic Decision Tree
flowchart TD
A[Respiratory disease in poultry flock] --> B[Clinical examination & necropsy]
B --> C{Suspicion of ORT?}
C -->|Yes| D[Collect tracheal/air sac swabs or tissue]
D --> E["Acute cases: Culture on blood agar + PCR"]
D --> F["Chronic cases: PCR + serology (ELISA")]
E --> G[ORT isolation?]
G -->|Positive| H[Confirm by MALDI-TOF or PCR]
G -->|Negative| I[Consider other pathogens]
F --> J[PCR positive?]
J -->|Yes| K[Confirm by sequencing if needed]
J -->|No| L[Serology positive?]
L -->|Yes| M[Evidence of past exposure]
L -->|No| N[Investigate non-ORT causes]
H --> O[Antimicrobial susceptibility testing]
O --> P[Select treatment based on MIC profile]
I --> Q[Test for aMPV, IBV, MG, MS, APEC, etc.]
Antimicrobial Susceptibility and Resistance
ORT isolates frequently exhibit multidrug resistance (MDR). Common antimicrobial classes used in poultry include tetracyclines, macrolides, penicillins, phenicols, and fluoroquinolones. Resistance profiles vary geographically and over time.
| Antimicrobial Class | Common Resistance Pattern | Notes |
|---|---|---|
| Tetracyclines | High resistance (60–90%) | Widespread due to use in feed [7, 36, 93] |
| Macrolides (tylosin, tilmicosin) | Variable (20–60%) | Resistance associated with ribosomal methylases [3, 6] |
| Beta-lactams (amoxicillin, ceftiofur) | Moderate to high | Beta-lactamase production reported [16, 93] |
| Phenicols (florfenicol) | Low to moderate (10–30%) | Effective in some regions [7] |
| Fluoroquinolones (enrofloxacin) | Variable (30–70%) | Resistance increasing [1, 36] |
The presence of integrative conjugative elements (ICEs) and plasmids carrying resistance genes has been documented [3, 6, 66]. Minimum inhibitory concentration (MIC) determination by broth microdilution or agar dilution is recommended for treatment guidance.
Treatment
Antimicrobial therapy should be based on susceptibility testing. Common therapeutic agents include:
- Macrolides: Tylosin, tilmicosin, gamithromycin. Gamithromycin has demonstrated favorable pharmacokinetic and pharmacodynamic properties against ORT in turkeys [88, 95].
- Phenicols: Florfenicol is often effective against MDR isolates.
- Tetracyclines: Doxycycline and chlortetracycline, though resistance is prevalent.
- Fluoroquinolones: Enrofloxacin and danofloxacin, but use should be cautious due to resistance and regulatory restrictions.
Administration is typically via drinking water or feed, but oral dosing may be less effective in birds with reduced water intake. Aivlosin (a macrolide) and zinc oxide nanoparticles have been investigated for synergistic effects against ORT and Mycoplasma gallisepticum coinfection [42].
Control and Prevention
Biosecurity
Strict biosecurity measures are essential to prevent introduction and spread of ORT. These include all-in/all-out stocking, cleaning and disinfection of barns between flocks, control of human and equipment movement, and separation of different age groups [17, 75]. Airborne transmission via dust and bioaerosols is a major route, and ventilation management is critical in reducing pathogen load [18, 17].
Vaccination
Both inactivated (bacterin) and live attenuated vaccines have been developed, but their efficacy varies by serotype. Autogenous vaccines prepared from specific field serotypes are commonly used. Studies in SPF chickens have shown that inactivated vaccines can reduce clinical signs and lesions [19, 67]. Oral vaccination strategies using IgY from hyperimmune egg yolk have also been explored [20]. The use of aMPV or IBV vaccination may reduce the severity of ORT disease by preventing viral predisposing infections [70, 88].
Management of Coinfections
Control of primary viral and mycoplasma infections is critical. Vaccination against aMPV, infectious bronchitis virus (IBV), Mycoplasma gallisepticum, and Avibacterium paragallinarum can lower the incidence of ORT-associated disease [21, 22, 23, 24, 62]. Improved gut health and immune modulation through nutritional strategies (e.g., arginine:lysine ratio, phytoncides) may also support respiratory defense [25, 50, 53, 58, 61].
Economic Impact
ORT infection leads to significant economic losses in poultry production. Direct losses include mortality (up to 30% in turkeys), reduced growth rates, increased feed conversion, and treatment costs. Indirect losses result from slaughterhouse condemnations due to airsacculitis and reduced egg production. In the United States, ORT is one of the most commonly diagnosed respiratory pathogens in turkeys, and it has been associated with flock-level losses of millions of dollars annually [1, 2, 94]. In other regions such as Morocco, Iran, Poland, and New Zealand, ORT is an emerging threat with substantial impact [26, 16, 27, 28, 37, 41, 48, 56, 78, 82, 83].
Conclusions
Ornithobacterium rhinotracheale is a globally important respiratory pathogen of poultry, with turkeys and chickens being the most affected hosts. The bacterium's ability to cause severe disease, high genetic variability, and increasing antimicrobial resistance pose serious challenges for diagnosis and control. Effective management requires integrated strategies including accurate laboratory diagnosis, prudent antimicrobial use, biosecurity, vaccination where feasible, and control of coinfecting pathogens. Future research should focus on improving vaccines, understanding pathogenesis at the molecular level, and developing rapid point-of-care diagnostics.
References
[1] Irwin J, Johnson TJ, Walters J. The Evolving Landscape of Ornithobacterium rhinotracheale in Turkeys: A Review. Avian Dis. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40249587/
[2] Campler MR, Hashish A, Ghanem M, et al. Space-Time Patterns of Poultry Pathogens in the USA: A Case Study of Ornithobacterium rhinotracheale and Pasteurella multocida in Turkey Populations. Pathogens. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/37623964/
[3] Blanda M, Kursa O, Kowalczyk J, et al. Whole-genome analysis of Ornithobacterium rhinotracheale from turkeys in Poland: Insights into global diversity, virulence, and antimicrobial resistance. Vet Microbiol. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41621167/
[4] Hashish A, Johnson TJ, Smith E, et al. Complete Genome Sequences of Three Ornithobacterium rhinotracheale Strains from Avian Sources, Using Hybrid Nanopore-Illumina Assembly. Microbiol Resour Announc. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/36719200/
[5] Rodrigo CH, Kulappu Arachchige SN, Zare S, et al. Comparative genomics of Ornithobacterium spp. isolated from free range layer chickens with respiratory infections unveils marked genetic diversity and putative new species. Vet Microbiol. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41581274/
[6] Palmieri N, Hess C, Pollák B, et al. Genomic analysis reveals two dominant strains of Ornithobacterium rhinotracheale in Austria and Hungary with distinct multidrug resistance profiles. Appl Environ Microbiol. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40689607/
[7] Blanda M, Śmiałek M, Kowalczyk J, et al. Identification, Serotyping and Antimicrobial Resistance in Ornithobacterium rhinotracheale Isolates from Turkeys in Poland Between 2016 and 2022. Animals (Basel). 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41594381/
[8] Rodrigo CH, Kulappu Arachchige SN, Bushell RN, et al. Complex pathogen interactions in upper respiratory tract infections in commercial free-range layers: A cross-sectional study. Vet Microbiol. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/42190304/
[9] Stępień-Pyśniak D, Dec M, Hauschild T, et al. Case reports involving coinfection with Avibacterium paragallinarum and Ornithobacterium rhinotracheale in broiler chickens and Avibacterium endocarditis in broiler breeding hens in Poland. Avian Pathol. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/38385975/
[10] Bashashati M, Shojaei M, Sabouri F. Pathogenic bacteria associated with outbreaks of respiratory disease in Iranian broiler farms. Vet Med Sci. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/37210710/
[11] Mirzazadeh A, Liebhart D, Mitsch P, et al. Recurring Airsacculitis in Late-Stage Production Leading to High Slaughterhouse Condemnation in a Commercial Turkey Farm. Avian Dis. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40643943/
[12] Krylova E, Bogomazova A, Kirsanova N, et al. Development and Validation of PCR Diagnostic Assays for Detection of Avibacterium paragallinarum and Ornithobacterium rhinotracheale. Vet Sci. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/38250913/
[13] Nguyen VG, Cao TB, Le VT, et al. A Multiplex PCR Method for Simultaneous Detection of Infectious Laryngotracheitis Virus and Ornithobacterium rhinotracheale. Vet Sci. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/37104427/
[14] Chrzastek K, Seal BS, Kulkarni A, et al. Whole-Genome Shotgun Sequencing from Chicken Clinical Tracheal Samples for Bacterial and Novel Bacteriophage Identification. Vet Sci. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40005922/
[15] Yousefinejad S, Khosravi M, Gharibi D, et al. Rapid detection of Ornithobacterium rhinotracheale infection by a latex agglutination test in turkeys. Poult Sci. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40318548/
[16] Bidoudan Y, Fellahi S, Fihri OF, et al. Ornithobacterium rhinotracheale in Moroccan Poultry: Antimicrobial Susceptibility Profiles, Characterization of Recent Isolates, and Retrospective Study (2019-23) of Its Occurrence in Different Poultry Production Systems. Avian Dis. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40249588/
[17] Sake B, Butenholz K, Kempf K, et al. Hybrid barn: the switch from a naturally to a mechanically ventilated turkey barn to protect from harmful bioaerosols. Front Vet Sci. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40046422/
[18] Ghaffar A, Liljebjelke K, Checkley SL, et al. Exploring the indoor airborne microbiome and resistome in layer barns across Alberta, Canada. Res Vet Sci. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/41075335/
[19] Ghodsian N, Shahsavandi S, Ebrahimi MM, et al. The Immunogenic Potential of an Inactivated Vaccine Candidate against Ornithobacterium Rhinotracheale in SPF Chicken. Arch Razi Inst. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/40256569/
[20] Aslam MS, Khalid S, Dar N, et al. Production of IgY in egg yolk of Gallus gallus Domesticus by oral vaccination and its characterization with outer membrane of Ornithobacterium rhinotracheale. Vet Immunol Immunopathol. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/39938275/
[21] Nguyen V, Ramsubeik S, Jerry C, et al. Avian Metapneumovirus Subtype A Infection in Commercial Chickens (Gallus gallus domesticus) and Turkeys (Meleagris gallopavo) in California. Avian Dis. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41739619/
[22] Frye E, Niel K, Davison S, et al. Overview of Avian Metapneumovirus Outbreak in Pennsylvania. Avian Dis. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41739615/
[23] Fasina YO, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) - Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poult Sci. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/38417326/
[24] Kursa O, Tomczyk G, Sieczkowska A, et al. Mycoplasma gallisepticum and Mycoplasma synoviae in Turkeys in Poland. Pathogens. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/38251385/
[25] Tykałowski B, Kowalczyk J, Ognik K, et al. Early post-hatching effects of antibiotics and ionophore coccidiostat supplementation on immune parameters in turkeys. Poult Sci. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40934714/
[26] Naseem MN, Bisset SW, Heng ZM, et al. Genetic analysis of Ornithobacterium rhinotracheale isolates: an Australian perspective. Avian Pathol. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/40905135/
[27] Zikibayeva KB, Svanbayev AA, Akhmetsadykov NN, et al. Epidemiological investigation of poultry infectious in Kazakhstan (2021-2024). Front Vet Sci. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/40008050/
[28] Ezdiyadi M, Khosropanah MK, Banani M, et al
[29] Han Q, Wang N, Feng T, et al. Characteristics of reproductive tract microbiota in health and disease. Microb Pathog. 2026. Available from: https://pubmed.ncbi.nlm.nih.gov/41936969/
[30] Shahsavandi S, Ghodsian N, Ebrahimi MM, et al. A phylogenetic landscape of Ornithobacterium rhinotracheale isolates from poultry in Iran presented based on 16S rRNA gene analysis. Arch Razi Inst. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/40256587/
[31] Li MN, Han Q, Wang N, et al. 16S rRNA gene sequencing for bacterial identification and infectious disease diagnosis. Biochem Biophys Res Commun. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/39550863/
[32] Smagieł R, Tutaj K, Cholewińska E, et al. The effect of early administration of antibiotics or feeding a diet containing coccidiostats on the level of their accumulation in liver and the redox status of turkeys. Animal. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/39326126/
[33] Li MN, Wang T, Wang N, et al. A detailed analysis of 16S rRNA gene sequencing and conventional PCR-based testing for the diagnosis of bacterial pathogens and discovery of novel bacteria. Antonie Van Leeuwenhoek. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/39012584/
[34] Romanenko L, Otstavnykh N, Kurilenko V, et al. Description and genome-wide analysis of Profundicola chukchiensis gen. nov., sp. nov., marine bacteria isolated from bottom sediments of the Chukchi Sea. PLoS One. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/37494411/
[35] Smagieł R, Ognik K, Cholewińska E, et al. The effect of early administration of antibiotics or feeding a diet containing a coccidiostat on inflammatory responses and the morphological structure of selected organs of the immune system in young meat-type turkeys. Poult Sci. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/37390558/
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.